These are the opening talks from this year's ODN Stakeholder Event from Mark Gillyon-Powell, Head of Programme for HCV Elimination, NHS England and Prof Graham Foster, National Clinical Lead for ODNs, NHS England.
The talks gives a national overview on hepatitis C elimination efforts in England and how COVID-19 has impacted these. Professor Guruprasad Aithal, President of the British Association for the Study of the Liver (BASL) chaired the event.
We will be publishing a written summary of the other presentations from this event soon.
Clinical Review of the Impacts of Hepatitis C: Short Life Working Group Report for the Scottish Government
Visit https://beta.gov.scot/publications/clinical-review-impacts-hepatitis-c-short-life-working-group-report/
This independent clinical review commissioned by the Scottish Government assesses the impacts of chronic hepatitis C infection on the health and wellbeing of individuals affected by contaminated blood and blood products. The review recommends that Scottish Infected Blood Support Scheme beneficiaries should be able to self-assess regarding the effect hepatitis C has had on their life, and which level of payment they are entitled to as a result. In October 2018, the Scottish Government confirmed it would accept the recommendations of this report.
